Advertisement

Topics

3rd Millennium, Inc Company Profile

19:56 EST 17th November 2017 | BioPortfolio

3rd Millennium, Inc. is the leading provider of custom informatics systems, management consulting services, and packaged software products for the life sciences.
Since 1994, we have helped both public and private life science institutions manage, plan, specify, design, build, and integrate informatics systems to support their research and development programs.

We provide our clients with outstanding value by combining our deep knowledge of life science R&D, cutting edge informatics technologies, a highly efficient methodology, and an extensive portfolio of designs, code libraries, frameworks, and implemented systems.

Our staff consists of Ph.D. level scientists and senior software engineers that work closely with our clients in tightly integrated teams. We have an unmatched record of completing projects on-time and on-budget while exceeding user expectations.

Location

391 Totten Pond Road, Suite 104
Waltham
Massachusetts
2451
United States of America

Contact

Phone: 781-890-4440
Email: eSales@3rdmill.com


News Articles [44 Associated News Articles listed on BioPortfolio]

Millennium:Looking for First in Class and Best in Class Opportunities in Oncology and Hematology

In this episode of PharmaTelevision News Review, filmed at #BIO2012 Convention in Boston, Fintan Walton talks to Dan Curran, Vice President, Corporate Development at Millennium

Gina Welsh’s newly released “How to Live in the Millennium” is a captivating take on life without Satan and how to live as heirs of God

(PRWEB) September 26, 2017 “How to Live in the Millennium”: a gripping take on how the author used personal experience to...

Millennium Health Receives MAGNET GROUP Contract for Pharmacogenetic Testing and Medication Monitoring

SAN DIEGO, Sept. 25, 2017 /PRNewswire/ -- The Mid-Atlantic Group Network of Shared Services (MAGNET GROUP), recently awarded Millennium Health, a leading health solutions company, with a contract for ...

MIT Medical to Implement Cerner Millennium EHR to Interact Seamlessly With Patients

MIT Medical, an ambulatory care center serving the 25,000+ members of the Massachusetts Institute Technology community has selected Cerner to implement an integrated clinical, financial and population...

Sareum and Structure: An Interview with Tim Mitchell, CEO

Fintan Walton talks to Tim Mitchell, CEO, Sareum, about founding the company with David Williams and John Reader, as a spin-out from Millennium Pharmaceuticals' Structure-based Discovery Department. T...

U.S. Department of Veterans Affairs Awards Millennium Health with Federal Supply Schedule Contract for Pharmacogenetic Testing

SAN DIEGO, Oct. 4, 2017 /PRNewswire/ -- In 2013, the U.S. Department of Veterans Affairs (VA) Office of Acquisition and Logistics National Acquisition Center awarded Millennium Health, a leading healt...

Millennium Equity Finance Corporation Acquires Sun Capsule

North Andover, MA, August 11, 2017 --(PR.com)-- The Sun Capsule brand has a new owner. Millennium Equity Finance Corporation assumed ownership and operation of the indoor tanning industry’s old...

US International Trade Association Complaint filed by Millennium Dental Technologies, Inc. against Fotona, LLC and Fotona, d.o.o.

WASHINGTON, Aug. 31, 2017 /PRNewswire/ -- Millennium Dental Technologies, Inc. (MDT) announced that it has filed a complaint against Fotona, LLC and Fotona d.o.o. (Fotona) with the U.S. Internati...

Drugs and Medications [0 Results]

None

PubMed Articles [33 Associated PubMed Articles listed on BioPortfolio]

An Update on the United Nations Millennium Development Goals.

The United Nations Millennium Development Goals initiative, designed to meet the needs of the world's poorest, ended in 2015. The purpose of this article is to describe the progress made through the M...

The last sigh and the death knell: a view on lung hyperinflation from a millennium ago.

The interventional cardiologist of the 3rd millennium.

Evolution of word meanings through metaphorical mapping: Systematicity over the past millennium.

One way that languages are able to communicate a potentially infinite set of ideas through a finite lexicon is by compressing emerging meanings into words, such that over time, individual words come t...

Long-Term Survivorship in Multiple Endocrine Neoplasia Type 2B diagnosed before and in the new Millennium.

Recent long-term outcome and survival data are lacking for patients with multiple endocrine neoplasia type 2B (MEN2B).

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

The Millennium Villages Project: Assessing the Impact on Child Survival and the Millennium Development Goals in Sub-Saharan Africa

The Millennium Villages Project involves the coordinated and simultaneous delivery of a package of proven interventions in health, agriculture, infrastructure and education. The project wo...

Treating Sleep Problems in VA Adult Day Health Care

The Veterans Millennium Health Care and Benefits Act (Millennium Act) of 1999 mandated the Department of Veterans Affairs (VA) to provide non-institutional long-term care to veterans. Adul...

MLN 9708 in Induction and Consolidation for Adults With AML >= 60 Years of Age

This research study is evaluating drugs called Millennium 9708 (referred to as MLN9708) in combination with standard therapy for acute myeloid leukemia (AML) consisting of daunorubicin and...

Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma

This is a research study to see if a new drug called bortezomib is useful to treat multiple myeloma in people who are newly diagnosed, and have not yet received treatment for their disease...

Study of Velcade® and Bone Formation in Patients With Relapsed/Refractory Multiple Myeloma

Velcade (bortezomib, PS-341) has recently been approved by the Food and Drug Administration (FDA) for the treatment of multiple myeloma (MM) for patients who have received at least one pri...

Companies [58 Associated Companies listed on BioPortfolio]

Millennium Dental Technologies, Inc.

Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a first-in-class proteasome inhibitor, and has a robust cl...

Millennium Pharmaceuticals, Inc.

Millennium Pharmaceuticals, The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a novel cancer product, and has a robust clinical developme...

Millennium: The Takeda Oncology Company

Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets a first-in-class proteasome inhibitor, and has a robust clinical de...

Millennium Pharmacy Systems, Inc.

Millennium Pharmacy Systems is a pharmacy services provider to the long-term care industry. Offering a new approach to pharmacy services, Millennium delivers on the promise of "the right drug, for th...

Millennium Marketing®

The mission of Millennium Marketing® is to provide businesses with information that will help them make more effective decisions.At Millennium Marketing® we will always do what's in the best int...

More Information about "3rd Millennium, Inc" on BioPortfolio

We have published hundreds of 3rd Millennium, Inc news stories on BioPortfolio along with dozens of 3rd Millennium, Inc Clinical Trials and PubMed Articles about 3rd Millennium, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of 3rd Millennium, Inc Companies in our database. You can also find out about relevant 3rd Millennium, Inc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record